Identification of patients at risk for poor survival among those with normal skeletal muscle mass: a multicenter retrospective validation study in gastric cancer - Report - MDSpire
Advertisement
Identification of patients at risk for poor survival among those with normal skeletal muscle mass: a multicenter retrospective validation study in gastric cancer
Clinical Report: Assessing Survival Risks in Gastric Cancer Patients
Overview
This study investigates the cutoff value for skeletal muscle mass index (SMI) that predicts poor long-term survival in gastric cancer patients without low skeletal muscle mass.
Background
Low skeletal muscle mass is associated with adverse postoperative outcomes in gastric cancer patients. As the population ages, the prevalence of low skeletal muscle mass is expected to rise.
Data Highlights
No numerical data provided in the source material.
Key Findings
Low skeletal muscle mass is linked to poor postoperative outcomes and long-term survival in gastric cancer patients.
The study aims to determine the cutoff value for SMI that predicts poor survival in patients without low skeletal muscle mass.
Patients without preoperative sarcopenia who develop postoperative sarcopenia have poorer long-term survival.
The study was conducted across 17 hospitals in Japan, focusing on patients who underwent radical gastrectomy.
Clinical Implications
Understanding the cutoff values for SMI can aid clinicians in identifying gastric cancer patients at risk for poor outcomes post-surgery.
Conclusion
Determining the appropriate SMI cutoff values is crucial for improving prognostic assessments in gastric cancer patients.
